Literature DB >> 27520653

Treatment thresholds for stroke prevention in atrial fibrillation: observations on the CHA2DS2-VASc score.

Thure Filskov Overvad1,2, Peter Brønnum Nielsen1,2, Gregory Y H Lip3,4.   

Abstract

Entities:  

Keywords:  Atrial fibrillation; Ischaemic stroke; Oral anticoagulation; Prevention

Mesh：

Substances：

Year:  2016        PMID： 27520653     DOI： 10.1093/ehjcvp/pvw022

Source DB:  PubMed          Journal:  Eur Heart J Cardiovasc Pharmacother


× No keyword cloud information.
  5 in total

1.  Dynamic stroke risk scores of atrial fibrillation.

Authors:  Minjae Yoon; Boyoung Joung
Journal:  J Thorac Dis       Date:  2018-03       Impact factor: 2.895

2.  Changes in oral anticoagulation for elective cardioversion: results from a European cardioversion registry.

Authors:  Judit Papp; Endre Zima; Ramon Bover; Rasa Karaliute; Andrea Rossi; Catherine Szymanski; Rossella Troccoli; Jonas Schneider; Morten Wang Fagerland; A John Camm; Dan Atar
Journal:  Eur Heart J Cardiovasc Pharmacother       Date:  2017-07-01

3.  Stroke and Systemic Thromboembolism according to CHA2DS2-VASc Score in Contemporary Korean Patients with Atrial Fibrillation.

Authors:  Kyung Bae Lee; Tae-Hoon Kim; Junbeom Park; Jin-Kyu Park; Ki-Woon Kang; Jun Kim; Hyung Wook Park; Eue-Keun Choi; Jin-Bae Kim; Young Soo Lee; Jaemin Shim; Boyoung Joung
Journal:  Yonsei Med J       Date:  2022-04       Impact factor: 2.759

4.  How does the TRS 2°P score relate to real-world patients?

Authors:  Marc P Bonaca; Gaetano M De Ferrari; Dan Atar; Lori D Bash; Dominik Lautsch; Erin A Bohula; Martin Horack; Philippe Brudi; Jean Ferrieres; Anselm K Gitt
Journal:  Eur Heart J Cardiovasc Pharmacother       Date:  2018-04-01

5.  Identification of Markers Associated With Development of Stroke in "Clinically Low-Risk" Atrial Fibrillation Patients.

Authors:  Seung Yong Shin; Sang-Jin Han; Jin-Seok Kim; Sung Il Im; Jaemin Shim; Jinhee Ahn; Eun Mi Lee; Yae Min Park; Jun Hyung Kim; Gregory Y H Lip; Hong Euy Lim
Journal:  J Am Heart Assoc       Date:  2019-10-31       Impact factor: 5.501
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.